Hyperglycemia in nondiabetic patients presenting with acute myocardial infarction

American Journal of the Medical Sciences

Volumn 343, Issue 4, 2012, Pages 321-326

  Shah, Binita ^a   Amoroso, Nicholas S ^a   Sedlis, Steven P ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute myocardial infarction; Diabetes mellitus; Hyperglycemia; Nondiabetic

Indexed keywords

ADENOSINE TRIPHOSPHATE; HEMOGLOBIN A1C;

ACUTE HEART INFARCTION; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HEART MUSCLE CONTRACTILITY; HUMAN; HYPERGLYCEMIA; MORTALITY; ORAL GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; STRESS;

EID: 84859105225     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31822fb423     Document Type: Review

References (62)

1. Qaseem A, Humphrey LL, Chou R, et al., on behalf of the Clinical Guidelines Committee of the American College of Physicians. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2011;154:260-7.
2. Kushner FG, Hand M, Smith SC, et al. 2009 Focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction and ACC/AHA/SCAI guidelines on percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol 2009;54:2205-41.
3. Levine SA. Coronary thrombosis; its various clinical features. Medicine 1929;8:245-418.
4. Haffner SM, Stern MP, Hazuda HP, et al. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990;263:2893-8.
5. Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002;359:2140-4. (Pubitemid 34694020)
6. Wahab NN, Cowden EA, Pearce NJ, et al. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002;40:1748-54. (Pubitemid 35341952)
7. Bolk J, van der Ploeg TJ, Cornel JH, et al. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 2001;79:207-14. (Pubitemid 32673682)
8. Ravid M, Berkowicz M, Sohar E. Hyperglycemia during acute myocardial infarction. A six-year follow-up study. JAMA 1975;233:807-9.
9. Soler NG, Frank S. Value of glycosylated hemoglobin measurements after acute myocardial infarction. JAMA 1981;246:1690-3. (Pubitemid 11015747)
10. Lakhdar A, Stromberg P, McAlpine SG. Prognostic importance of hyperglycemia induced by stress after acute myocardial infarction. Br Med J 1984;288:288. (Pubitemid 14085706)
11. Tenerz A, Lonnberg I, Berne C, et al. Myocardial infarction and prevalence of diabetes mellitus. Is increased casual blood glucose at admission a reliable criterion for the diagnosis of diabetes? Eur Heart J 2001;22:1102-10. (Pubitemid 32666651)
12. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33:S62-9.
13. McDonald L, Baker C, Bray C. Plasma catecholamines after cardiac infarction. Lancet 1969;2:1021-3.
14. Lykonsky PE, Oganov RG. Blood plasma catecholamines and their urinary excretion in patients with acute myocardial infarction. Am Heart J 1972;83:182-8.
15. Karlsberg PP, Cryer PE, Roberts R. Serial plasma catecholamines response early in the course of clinical acute myocardial infarction: relation to infarct extent and mortality. Am Heart J 1981;102:24-9. (Pubitemid 11086984)
16. Prakash R, Parmley NW, Horkat M. Serum cortisol, plasma free fatty acids and urinary catecholamines as indicators of complications in acute myocardial infarction. Circulation 1972;45:736-45.
17. Burckhardt P, Felber JP, Peret C. Adrenocortical, insulin and metabolic changes in response to acute myocardial infarction. Helv Med Acta 1972;36:277-93.
18. Bailey RR, Abernthy MH, Beaven DW. Adrenocortical response to the stress of acute myocardial infarction. Lancet 1967;1:970-3.
19. Bloom SR, Daniel PM, Johnson DI. Release of glucagon induced by stress. Q J Exp Physiol Cogn Med Sci 1973;58:99-108.
20. Willerson JT, Hutcheson DR, Leshin SJ, et al. Serum glucagon and insulin levels and their relationship to blood glucose values in patients with acute myocardial infarction and acute coronary insufficiency. Am J Med 1974;57:747-53.
21. Taylor SH, Majind PA, Gosh P. Insulin secretion following myocardial infarction. Lancet 1969;2:1373-7.
22. Dykes JRW, Saxton c, Taylor SH. Insulin secretion in cardiogenic shock. Br Med J 1969;2:490-3.
23. Vetter NJ. Initial metabolic and hormonal response to acute myocardial infarction. Lancet 1974;1:284-8.
24. Oswald GA, Smith CCT, Betteridge DJ, et al. Determinants and importance of stress hyperglycemia in non-diabetic patients with myocardial infarction. Br Med J 1986;293:917-22. (Pubitemid 16002429)
25. Shechter M, Merz CN, Paul-Labrador MJ, et al. Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease. J Am Coll Cardiol 2000;35:300-7. (Pubitemid 30125517)
26. Guyader AL, Pacheco G, Seaver N, et al. Inhibition of platelet GPIIb-IIIa and P-selectin expression by aspirin is impaired by stress hyperglycemia. J Diabetes Complications 2009;23:65-70.
27. Davi G, Catalano I, Averna M, et al. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 1990;322: 1769-74. (Pubitemid 20194655)
28. Juhan-Vague I, Alessi MC, Vague P. Increased plasma plasminogen activator inhibitor 1 levels: a possible link between insulin resistance and atherothrombosis. Diabetologia 1991;34:457-62.
29. Schneider DJ, Nordt TK, Sobel BE. Attenuated fibrinolysis and accelerated atherogenesis in type 2 diabetic patients. Diabetes 1993;42: 1-7. (Pubitemid 23013788)
30. Williams SB, Goldfine AB, Timimi FT, et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 1998;97:1695-1701. (Pubitemid 28211418)
31. Kawano H, Motoyama T, Hirashima O, et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 1999;34:146-54.
32. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1990;322:1769-74.
33. Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 2000;404:787-90. (Pubitemid 30212409)
34. Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002;106:2067-72. (Pubitemid 35192812)
35. Nappo F, Esposito K, Cioffi M, et al. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol 2002;39:1145-50. (Pubitemid 34267417)
36. Iwakura K, Ito H, Ikushima M, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 2003;41:1-7. (Pubitemid 36044395)
37. Marfella R, Siniscalchi M, Esposito K, et al. Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care 2003; 26:3129-35. (Pubitemid 37339509)
38. Marfella R, Filippo CD, Portoghese M, et al. Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients. J Am Coll Cardiol 2009;53:1425-36.
39. Ishihara M, Inoue I, Kawagoe T, et al. Effect of acute hyperglycemia on the ischemic preconditioning effect of prodromal angina pectoris in patients with a first anterior wall acute myocardial infarction. Am J Cardiol 2003;92:288-91. (Pubitemid 36897712)
40. Holubarasch C, Ruf T, Goldstein DJ, et al. Existence of the Frank- Starling mechanism in the failing human heart: investigation on the organ, tissue, and sarcomere levels. Circulation 1996;94:683-9. (Pubitemid 26289222)
41. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischemia and arrhythmias. Lancet 1994;343:155-8.
42. Eberli FR, Weinberg EO, Grice WN, et al. Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions. Circ Res 1991;68:466-81.
43. Mjos OD. Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs. J Clin Investig 1971;50:1386-9.
44. Leor J, Goldbourt U, Reicher-Reiss H, et al. Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. Am J Med 1993;94:265-73. (Pubitemid 23074800)
45. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000;355:773-8. (Pubitemid 30128815)
46. Stranders I, Diamant M, van Gelder RE, et al. Admission glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 2004;164:982-8. (Pubitemid 38581518)
47. Bellodi G, Manicardi V, Malavasi V, et al. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 1989;64:885-8. (Pubitemid 19246163)
48. Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in non-diabetic patients. Diabetes Care 1999; 22:1827-31. (Pubitemid 29521869)
49. Timmer JR, Van der Horst IC, Ottervanger JP, et al. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J 2004;148:399-404. (Pubitemid 39265111)
50. Straumann E, Kurz DJ, Muntwyler J, et al. Admission glucose concentrations independently predict early and late mortality in patients with acute myocardial infarction treated by primary or rescue percutaneous coronary intervention. Am Heart J 2005;150:1000-6. (Pubitemid 41607787)
51. Gasior M, Pres D, Stasik-Pres G, et al. Effect of blood glucose levels on prognosis in acute myocardial infarction in patients with and without diabetes, undergoing percutaneous coronary intervention. Cardiol J 2008;15:422-30.
52. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005;111:3078-86. (Pubitemid 40847785)
53. Suleiman M, Hammerman H, Boulos M, et al. Fasting glucose is an independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 2005;111: 754-60. (Pubitemid 40250636)
54. Lavi S, Kapeliovich M, Grugberg L, et al. Hyperglycemica during acute myocardial infarction in patients who are treated by primary percutaneous coronary intervention: impact on long-term prognosis. Int J Cardiol 2008;123:117-22. (Pubitemid 350250888)
55. Aronson D, Hammerman H, Suleiman M, et al. Usefulness of changes in fasting glucose during hospitalization to predict long-term mortality in patients with acute myocardial infarction. Am J Cardiol 2009;104:1013-7.
56. Bartnik M, Malmberg K, Norhammar A, et al. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J 2004;25:1990-7. (Pubitemid 39486017)
57. Malmberg K, Norhammar A, Wedel H, et al. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: longterm results from the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study. Circulation 1999;99:2626-32. (Pubitemid 29237448)
58. Malmberg K, Ryden L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005;26:650-61. (Pubitemid 40516876)
59. Cheung NW, Wong VW, McLean M. The hyperglycemia: intensive insulin infusion in infarction (HI-5) study. A randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 2006;29:765-70. (Pubitemid 44115291)
60. Mehta SR, Yusuf S, Diaz R, et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005;293:437-46.
61. Krljanac G, Vasiljevic Z, Radovanovic M. Effects of glucose-insulin- potassium infusion on ST-elevation myocardial infarction in patients treated with thrombolytic therapy. Am J Cardiol 2005;96:1053-8. (Pubitemid 41416594)
62. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009;32:1119-31.